Zurcher Kantonalbank (Zurich Cantonalbank) G1 Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023
BUY
$2.57 - $8.16 $31,186 - $99,021
12,135 New
12,135 $32,000
Q2 2022

Aug 09, 2022
SELL
$4.04 - $8.51 $20,676 - $43,554
-5,118 Closed
0 $0
Q4 2020

Jan 28, 2021
BUY
$10.99 - $20.4 $25,035 - $46,471
2,278 Added 80.21%
5,118 $92,000
Q2 2020

Jul 28, 2020
BUY
$9.57 - $24.37 $16,661 - $42,428
1,741 Added 158.42%
2,840 $69,000
Q4 2018

Jan 25, 2019
BUY
$16.51 - $51.33 $10,417 - $32,389
631 Added 134.83%
1,099 $21,000
Q3 2018

Nov 09, 2018
BUY
$43.15 - $67.97 $20,194 - $31,809
468 New
468 $24,000

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email